Zydus Cadila Shares Gain As Subsidiary Receives USFDA Nod To Market Tamiflu Drug

New Delhi: Shares of drug firm Zydus Cadila gained on Monday after its US subsidiary received approval from the US health regulator to market oseltamivir phosphate capsules used for the treatment of Tamiflu. "Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the United States Food and Drug Administration (USFDA) to market oseltamivir phosphate capsules in strengths of 30 mg, 45 mg...